What is Vir Biotechnology, Inc.'s D&A?

Vir Biotechnology, Inc. (VIR) reported D&A of $2.81M in Q1 2026.

How has Vir Biotechnology, Inc.'s D&A changed year-over-year?

Vir Biotechnology, Inc.'s D&A decreased by 2.0% year-over-year, from $2.87M to $2.81M.

What is the long-term trend for Vir Biotechnology, Inc.'s D&A?

Over 4 years (2021 to 2025), Vir Biotechnology, Inc.'s D&A has grown at a 21.5% compound annual growth rate (CAGR), from $5.36M to $11.68M.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Vir Biotechnology, Inc. VIR D&A

D&A at other companies

AmgenAMGN

$1.12B-19.5%

Regeneron PharmaceuticalsREGN

$123.2M-2.9%

Viridian Therapeutics, Inc.VRDN

$121K+3.4%

Iovance Biotherapeutics, Inc.IOVA

$2.82M+9.8%

Nuvation BioNUVB

$536K+72.9%

Enliven TherapeuticsELVN

$14K-81.1%

Other financials

Income statement

See full

Revenue-$29.0K-101%

Gross profit$1.2M-60.2%

Operating income-$132.3M+5.2%

Net income-$125.7M-3.9%

EPS (diluted)-$0.85+3.4%

Balance sheet

See full

Cash & equivalents$283.0M-23.1%

Total debt$95.6M-0.5%

Total equity$812.8M-22.1%

Total assets$1.0B-21.6%

Cash flow

See full

Operating cash flow-$132.4M-69.5%

CapEx$390.0K-76.1%

Free cash flow-$132.8M-66.5%

Valuation

See full

Market cap$1.71B+61.1%

Enterprise value$1.53B+102%

P/S26.2×-24.8×

Profitability

See full

Gross margin96.1%-2.7pp

Operating margin-720.8%-313pp

Net margin-676%-291pp

FCF margin-686.5%-273pp

Returns & leverage

See full

Return on equity-47.7%+3.6pp

Debt / equity0.1×0.0×

Current ratio7.1×+0.3×

Where this comes from

Reported directly by Vir Biotechnology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vir Biotechnology, Inc.'s d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vir Biotechnology, Inc.'s D&A?: Vir Biotechnology, Inc. (VIR) reported D&A of $2.81M in Q1 2026.
How has Vir Biotechnology, Inc.'s D&A changed year-over-year?: Vir Biotechnology, Inc.'s D&A decreased by 2.0% year-over-year, from $2.87M to $2.81M.
What is the long-term trend for Vir Biotechnology, Inc.'s D&A?: Over 4 years (2021 to 2025), Vir Biotechnology, Inc.'s D&A has grown at a 21.5% compound annual growth rate (CAGR), from $5.36M to $11.68M.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.